Home / Brands / Dragon Pharma / Dragon Pharma GW 501516 20 mg - Cardarine PPAR Delta Agonist
U.S Domestic
Dragon Pharma GW 501516 20 mg - Cardarine PPAR Delta Agonist
Dragon Pharma

Dragon Pharma GW 501516 20 mg - Cardarine PPAR Delta Agonist

Oral · 20 mg/tab · 100 tabs

In stock · ships within 24h Out of stock
$140.00

Dragon Pharma GW 501516 20 mg is cardarine, a PPAR-delta agonist supplied as 100 tablets of 20 mg. It is not a SARM and not a steroid despite sitting in the SARM category: it works on metabolic gene signalling, not the androgen receptor.

Each pack is GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. GW 501516 20 mg for sale with U.S. and international shipping.

Shipping Not available in this combination
1
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Dragon Pharma GW 501516 20 mg - Cardarine PPAR-Delta Agonist

Dragon Pharma GW 501516 20 mg supplies cardarine as 100 tablets of 20 mg. The compound is a PPAR-delta agonist, a metabolic receptor activator studied for endurance and fat oxidation, and it is deliberately not an androgen: it does not bind the androgen receptor and does not suppress the hormonal axis. Cardarine for sale from a GMP manufacturer with batch testing and a Certificate of Analysis on file.

  • GW 501516 (cardarine) 20 mg per tablet, 100 tablets per pack
  • PPAR-delta agonist - not a SARM and not a steroid
  • No half-life established in the cited sources
  • GMP-manufactured, HPLC-verified, COA on file per batch

How GW 501516 Works

PPAR-delta is a nuclear receptor that shifts muscle towards fat oxidation and changes the expression of metabolic genes, which is why it is described as an endurance and recomp agent rather than a muscle builder. It does not touch the androgen receptor, so suppression of natural testosterone is not part of its profile and recovery with a SERM is not required on its own. That is the key difference from Ostarine, Ligandrol and Ibutamoren, which act on the androgen or ghrelin receptors instead. No half-life is established in the cited sources, so timing is described only through campaign ranges.

Research Amounts and Handling

No human dose is approved, so every figure is a community campaign range. Reported practice runs at 10 mg per day at the low end, 10 to 20 mg per day in the middle, and 20 mg per day at the top, over campaigns of 8 to 12 weeks, with the 20 mg tablet on this page at the upper end of that range. The safety signal that cannot be left out is the carcinogenic finding in rodent models at 3 mg per kg per day, whose meaning for humans is unknown. Headache, nausea and fatigue are the reported effects.

Quality & Authenticity

Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch, Cardarine is often stacked in community reporting with Ostarine or with SLU-PP-332, another metabolic research compound from a different pharmacological family, and none of those combinations carries separate safety data. The Zyvex Cardarine card carries the same substance under another brand.

For laboratory research only. Consult a healthcare professional before use.

Specifications

Trade NameGW 501516
Generic NameCardarine (GW-501516)
ManufacturerDragon Pharma
Dosage20 mg per tablet
Package100 tablets per pack
Drug ClassPPAR-delta agonist (metabolic modulator, not a SARM)
AdministrationOral, once daily
Reference Half-LifeNot established in the cited sources
ShippingInternational and U.S. domestic options

Stacks

Endurance Campaign

A 8 to 12 week campaign at 10 to 20 mg daily, kept as the only metabolic compound in the protocol so the response is attributable.

Outcome: a defined campaign window with one variable instead of several at once.

Monitoring: no human dose is approved, and the rodent carcinogenic signal is the primary safety caveat.

Metabolic Pairing With SLU-PP-332

Cardarine next to SLU-PP-332 as a second metabolic research compound, with each product kept to its own reported campaign range.

Outcome: two distinct metabolic pathways are studied without layering extra androgen receptor load.

Monitoring: no combination safety data exist; both compounds remain research-only materials.

Consult a healthcare professional before any cycle. Doses are common community protocols.

FAQ

Before you ask

Questions, answered

It is cardarine, a PPAR-delta agonist supplied as 20 mg tablets, 100 per pack. It is not a SARM and not a steroid even though it sits in the SARM category on the storefront. It has no approved human label, no established half-life in the cited sources and thin human safety data, so it is a research compound.

PPAR-delta is a nuclear receptor that shifts muscle towards fat oxidation and changes metabolic gene expression. That is why the compound is described in research as an endurance and recomp agent rather than as a muscle builder. It does not bind the androgen receptor, so it does not suppress natural testosterone the way SARMs do and does not require PCT on its own.

No dose is approved, so the figures are community campaign ranges. Reported practice runs at 10 mg per day at the low end, 10 to 20 mg per day in the middle, and 20 mg per day at the top over 8 to 12 week campaigns. The 20 mg tablet on this page sits at the upper end of that reported range, and amounts above it are outside the data.

Headache, nausea and fatigue are the reported effects, and human safety data are generally thin. The signal that has to be stated plainly is that GW 501516 was carcinogenic in rodent models at 3 mg per kg per day; the meaning of that finding for humans is unknown, and the compound is not considered a safe option by any regulatory body.

No, not on its own. GW 501516 does not act on the androgen receptor and does not suppress the hormonal axis, so a SERM is not required for cardarine alone. If it is stacked with a SARM such as Ostarine or Ligandrol, then recovery is planned for that suppressive compound and not for the cardarine.

Yes. The 20 mg, 100 tablet pack is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine in any country.

No reviews yet

Be the first to share your experience with Dragon Pharma GW 501516 20 mg - Cardarine PPAR Delta Agonist

Log in to write a review